STI 2018
Understanding and Addressing the HIV and STI Syndemics
21-22 July 2018 | Amsterdam, the Netherlands

HIV and other sexually transmitted infections (STIs) have been inextricably linked since the start of the HIV epidemic. A new era of global health and development driven by the Sustainable Development Goals (SDGs) offers a fresh opportunity to address the critical health issue of STIs through greater involvement, interaction and coordination between the HIV and STI fields. The 22nd International AIDS Conference (AIDS 2018) in Amsterdam, with its focus on HIV within the broader global health context, offers an excellent opportunity to explore the state of knowledge, best practices and a research agenda regarding HIV and STIs.

In the era of universal treatment and pre-exposure prophylaxis (PrEP) STI 2018 will identify new challenges, emerging issues, and opportunities for research and programme implementation to counter increases in bacterial STIs (i.e. syphilis, gonorrhoea and chlamydia) being observed in many settings. The conference will explore critical issues related to antimicrobial resistance and reproductive, maternal, newborn, child, and adolescent health to ensure an integrated approach.

STI 2018 will combine keynote presentations and roundtable discussions to provide a thorough investigation of the current state-of-the-art in STI prevention, treatment and care specifically in the context of the HIV epidemic. It will include a number of overarching themes looking at the interface between the two disease areas. The meeting will be organized as an official pre-conference to AIDS 2018 at the RAI Amsterdam on 21-22 July 2018 with an expected attendance of 400-500 scientists, clinicians, programme implementers, advocates and community representatives.

Organizing Committee

Co-chairs
Ken Mayer, The Fenway Institute, United States
Henry de Vries, Public Health Service of Amsterdam (GGD) | Academic Medical Centre, University of Amsterdam, The Netherlands

Members
Birgit van Benthem, National Institute for Public Health and the Environment (RIVM), The Netherlands
Jan van Bergen, Soa Aids Nederland, Amsterdam | Academic Medical Center, University of Amsterdam |  National Institute for Public Health and the Environment (RIVM), The Netherlands
Silke David, National Institute for Public Health and the Environment (RIVM), The Netherlands
Udi Davidovich, Public Health Service of Amsterdam (GGD), The Netherlands
Arjan Hogewoning, Public Health Service of Amsterdam (GGD), The Netherlands
Elske Hoornenborg, Public Health Service of Amsterdam (GGD) The Netherlands
Marina Klein, McGill University and CIHR Canadian HIV Trials Network, Canada
Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology, Kenya | Department of Global Health, University of Washington, United States
Nneka Nwokolo, Chelsea and Westminster Hospital, United Kingdom
Maria Oud, Public Health Service of Amsterdam (GGD), The Netherlands
Sébastien Morin, International AIDS Society, Switzerland
Maria Prins, Public Health Service of Amsterdam (GGD) | Academic Medical Center, University of Amsterdam, The Netherlands
Jürgen Rockstroh, University of Bonn, Germany
Mauro Schechter, Universidade Federal do Rio de Janeiro, Brazil
Maarten Schim van der Loeff, Public Health Service of Amsterdam (GGD) | Academic Medical Center, University of Amsterdam, The Netherlands
Darrell Tan, Li Ka Shing Knowledge Institute, Canada
Clarissa Vergunst, Public Health Service of Amsterdam (GGD), The Netherlands

With support from